Immunohistochemistry (IHC): Global Markets to 2022

Summary Table: Global Immunohistochemistry Market, by Product, Through 2022
Table 1: Immunohistochemistry Laboratory Standards and Regulations
Table 2: U.S. Centers for Disease Control Biosafety Regulations
Table 3: Antibody Manufacturers and Products Available in the Global Immunohistochemistry Market
Table 4: Global Immunohistochemistry Market, by Product, Through 2022
Table 5: Global Immunohistochemistry Market, by Antibodies, Through 2022
Table 6: Diabetes Incidence in the Top 10 Countries, 2016
Table 7: Global Antibodies Market, by Region, Through 2022
Table 8: Global Primary Antibodies Market, by Region, Through 2022
Table 9: Examples of Clinically Important Monoclonal Antibodies
Table 10: Secondary Antibody Selection
Table 11: Global Secondary Antibodies Market, by Region, Through 2022
Table 12: Global Immunohistochemistry Market, by Equipment, Through 2022
Table 13: Global Immunohistochemistry Equipment Market, by Region, Through 2022
Table 14: Global Slide Staining Systems Market, by Region, Through 2022
Table 15: Estimated Number of U.S. Cancer Survivors, by Sex and Survival Years, as of Jan. 1, 2016
Table 16: Global Tissue Microarrays Market, by Region, Through 2022
Table 17: Healthcare Spending by Different Income Level Countries, 2040
Table 18: Global Tissue Processing Systems Market, by Region, Through 2022
Table 19: Global Slide Scanners Market, by Region, Through 2022
Table 20: Global Other Equipment Market, by Region, Through 2022
Table 21: Global Immunohistochemistry Market, by Reagent, Through 2022
Table 22: Global Reagents Market, by Region, Through 2022
Table 23: Global Histological Stains Market, by Region, Through 2022
Table 24: Categories of Histological Stains
Table 25: Global Blocking Sera and Reagents Market, by Region, Through 2022
Table 26: Global Chromogenic Substrates Market, by Region, Through 2022
Table 27: Global Fixation Reagents Market, by Region, Through 2022
Table 28: Most Common Fixatives and Their General Target Antigens
Table 29: Global Stabilizers Market, by Region, Through 2022
Table 30: The Most Common Causes of Cancer Death, 2015
Table 31: Global Organic Solvents Market, by Region, Through 2022
Table 32: Global Proteolytic Enzymes Market, by Region, Through 2022
Table 33: Global Diluents Market, by Region, Through 2022
Table 34: Kit Components for Immunohistochemistry Optimization
Table 35: Global IHC Kits Market, by Region, Through 2022
Table 36: Global Immunohistochemistry Market, by Application, Through 2022
Table 37: Global Immunohistochemistry Diagnostics Market, by Application, Through 2022
Table 38: Global Immunohistochemistry Diagnostics Market, by Region, Through 2022
Table 39: Global Cancer Diagnostics Market, by Region, Through 2022
Table 40: Global Immunohistochemistry Infectious Disease Applications Market, by Region, Through 2022
Table 41: Global Immunohistochemistry Cardiovascular Disease Applications Market, by Region, Through 2022
Table 42: Selected Infectious Etiologies of Autoimmune Diseases
Table 43: Global Immunohistochemistry Autoimmune Disease Applications Market, by Region, Through 2022
Table 44: Diabetes Incidence in the Top 10 Countries, 2016
Table 45: Global Immunohistochemistry Diabetes Mellitus Applications Market, by Region, Through 2022
Table 46: Global Immunohistochemistry Nephrological Disease Applications Market, by Region, Through 2022
Table 47: Global Immunohistochemistry Drug Testing Applications Market, by Region, Through 2022
Table 48: Global Immunohistochemistry Market, by End User, Through 2022
Table 49: Global Immunohistochemistry Hospital and Diagnostic Laboratory Applications Market, by Region, Through 2022
Table 50: Various Cancer Research Studies
Table 51: Global Immunohistochemistry Research Institute Applications Market, by Region, Through 2022
Table 52: Uses of Immunohistochemistry in Forensic Pathology
Table 53: Global Immunohistochemistry Other End User Applications Market, by Region, Through 2022
Table 54: Global Immunohistochemistry Market, by Region, Through 2022
Table 55: Grants by Type of Cancer, 2017
Table 56: Estimated New Cancer Cases in Males in Canada, 2017
Table 57: Estimated New Cancer Cases in Females in Canada, 2017
Table 58: Deaths from CVD and Number of People Living with CVD in the U.K., 2017
Table 59: Death Rate Due to Cardiovascular Diseases in the U.K., 2017
Table 60: Deaths Caused by Cardiovascular Disease Compared with Other Causes of Death in Germany, 2016
Table 61: Diseases Causing the Greatest Number of Premature Deaths in Germany, Percentage Change from 2005-2016
Table 62: Cancer Incidence Rates in Asia-Pacific, 2016
Table 63: Mortality Rates in Asia-Pacific, by Cancer Type, 2016
Table 64: Top Five Types Cancer in Men and Women in India, 2017
Table 65: Estimated Incidence of All Cancers in Australia, by Sex, 2017
Table 66: Estimated 20 Most Commonly Diagnosed Cancers in Males in Australia, 2017
Table 67: Estimated 20 Most Commonly Diagnosed Cancers in Females in Australia, 2017
Table 68: 10 Most Common Cancers in Australia Considering Principal Diagnosis, 2014-2015 (Number/%)
Table 69: Estimated 10 Most Common Causes of Death from Cancer in Males in Australia, 2017
Table 70: Estimated 10 Most Common Causes of Death from Cancer in Females in Australia, 2017
Table 71: Percentage of Population in Brazil, Age 60 and Above
Table 72: Top 10 Causes of Death in Mexico and Percentage Increase from 2005-2016
Table 73: Top 10 Causes of Death in Argentina and Percentage Change, 2005-2016
Table 74: Top 10 Causes of Death in Cuba and Percentage Change, 2005-2016
Table 75: Impact Analysis of Market Drivers
Table 76: Cancer Markers Used in the Diagnosis and Treatment of Different Types of Cancer
Table 77: Global Population Aged 60 Years and Above, by Region
Table 78: Global Population Aged 80 Years and Above, by Region
Table 79: Countries with the Highest Elderly Populations, 2015 and 2030
Table 80: Abbott Laboratories: Product Portfolio
Table 81: Abcam: Product Portfolio
Table 82: Abcam Recent Developments, 2015-2018
Table 83: Abnova: Product Portfolio
Table 84: Agilent Technologies Inc.: Product Portfolio
Table 85: Agilent Technologies Inc. Recent Developments, 2015-2018
Table 86: Arrayit Corp.: Product Portfolio
Table 87: Arrayit Corp. Recent Developments, 2015-2018
Table 88: Bio SB: Product Portfolio
Table 89: Bio SB Recent Developments, 2015-2018
Table 90: Biocare Medical: Product Portfolio
Table 91: Biocare Medical Recent Developments, 2015-2018
Table 92: Biogenex: Product Portfolio
Table 93: Biogenex Recent Developments, 2015-2018
Table 94: BioLegend: Product Portfolio
Table 95: Bio-Rad Laboratories Inc.: Product Portfolio
Table 96: Candor Bioscience Gmbh: Product Portfolio
Table 97: Cell Marque Corp.: Product Portfolio
Table 98: Cell Signaling Technology Inc.: Product Portfolio
Table 99: Cell Signaling Technology Inc.Recent Developments, 2015-2018
Table 100: Danaher Corp.: Product Portfolio
Table 101: Danaher Corp. Recent Developments, 2015-2018
Table 102: Diagnostic Biosystems Inc.: Product Portfolio
Table 103: F. Hoffmann-La Roche Ag: Product Portfolio
Table 104: F. Hoffmann-La Roche Ag Recent Developments, 2015-2018
Table 105: Histologix: Product Portfolio
Table 106: Immunologic: Product Portfolio
Table 107: LSBio: Product Portfolio
Table 108: Merck Millipore: Product Portfolio
Table 109: Novodiax: Product Portfolio
Table 110: Novodiax Recent Developments, 2015-2018
Table 111: PeproTech Gmbh: Product Portfolio
Table 112: Perkinelmer Inc.: Product Portfolio
Table 113: Rockland Immunochemicals: Product Portfolio
Table 114: Sakura Finetek Usa Inc.: Product Portfolio
Table 115: Sakura Finetek Usa Inc. Recent Developments, 2015-2018
Table 116: Siemens AG Healthcare: Product Portfolio
Table 117: Thermo Fisher Scientific Inc.: Product Portfolio
Table 118: Thermo Fisher Scientific Inc. Recent Developments, 2015-2018
Table 119: Vector Laboratories: Product Portfolio
Table 120: Vector Laboratories Recent Developments, 2015-2018

Summary Figure: Global Market for Immunohistochemistry, by Product, 2016-2022
Figure 1: Outline of The Steps Needed to Localize Antigens in IHC Testing
Figure 2: Immunohistochemistry Timeline
Figure 3: Immunohistochemistry Test Procedure
Figure 4: Global Immunohistochemistry Market Shares, by Product, 2016 and 2022
Figure 5: Phases of Histological Staining
Figure 6: Global Immunohistochemistry Market Shares, by Application, 2016 and 2022
Figure 7: Global Immunohistochemistry Market Shares, by End User, 2016 and 2022
Figure 8: Global Immunohistochemistry Market Shares, by Region, 2016 and 2022
Figure 9: Global Immunohistochemistry Market Shares, by Product, 2016 and 2022
Figure 10: Number of Cancer Cases Worldwide, 2012 and 2030
Figure 11: Number of People with Chronic Conditions in the United States, 2010-2025
Figure 12: Percentage Distribution of Population Aged 65 and Over, by Region, 2015 and 2050
Figure 13: Global Immunohistochemistry Market Share, by Service, 2016
Figure 14: Number of New TB Cases, 2016
Figure 15: New HIV Diagnoses in the United States, by Age, 2016
Figure 16: Estimated Number of Colon Cancer Cases in the U.S, 2017 and 2018
Figure 17: Global Immunohistochemistry Market Shares, by Application, 2016 and 2022
Figure 18: Global Prevalence of Colon Cancer, by Age, 2016
Figure 19: New Global HIV Infections, by Region, 2016
Figure 20: Healthcare Expenditures Across the Globe, 2014-2016
Figure 21: Healthcare Cost Comparison of Autoimmune Diseases and Cancer, 2015
Figure 22: Global Prevalence of Diabetes, by Age Group and Region
Figure 23: Global Prevalence of Chronic Kidney Diseases, by Age
Figure 24: Global Development of Medicines, by Disease Type
Figure 25: Global Share of R&D Spending on Drug Testing, by Region, 2016
Figure 26: Global Immunohistochemistry Market Shares, by End User, 2016 and 2022
Figure 27: Global Incidence of Patients with Chronic Diseases, 2005-2030
Figure 28: New Cases of Cancer in France, 2015
Figure 29: Health Spending and Financing in France, 2005-2015
Figure 30: Market Demand for Medical Equipment in France
Figure 31: Healthcare Spending in Mexico, 2014 and 2040
Figure 32: Healthcare Spending in Argentina, 2014 and 2040
Figure 33: Healthcare Expenditures and Financing in Chili, 2005-2016
Figure 34: Healthcare Spending in Cuba, 2014 and 2040
Figure 35: Global GDP Shares of Healthcare Expenditures and Financing, by Country 2010-2016